Cargando…
1581. Comparative In Vitro Activity of Ceftolozane/tazobactam and Comparator Agents Against Enterobacteriaceae and Pseudomonas Aeruginosa Clinical Isolates in Colombia
BACKGROUND: Multidrug-resistant Enterobacteriaceae (Ent) and Pseudomonas aeruginosa (Pae) are involved in a considerable number of healthcare-associated infections, thus representing a therapeutic challenge. Ceftolozane–tazobactam (C/T) is a combination of a novel cephalosporin with a known β-lactam...
Autores principales: | Hernández-Gómez, Cristhian, De La Cadena, Elsa, Mojica, Maria F, Correa, Adriana, Perengüez, Marcela, Gutiérrez, Sergio, Pallares, Christian, López, Catalina, Maria. Rojas Rojas, Monica, Virginia Villegas, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809320/ http://dx.doi.org/10.1093/ofid/ofz360.1445 |
Ejemplares similares
-
Comparative In Vitro Activity of Ceftolozane/Tazobactam against Clinical Isolates of Pseudomonas aeruginosa and Enterobacterales from Five Latin American Countries
por: García-Betancur, Juan Carlos, et al.
Publicado: (2022) -
612. Molecular Mechanisms Leading to Ceftolozane–Tazobactam Resistance in Clinical Isolates of Pseudomonas aeruginosa from Five Latin American Countries
por: Mojica, Maria F, et al.
Publicado: (2019) -
2062. Evaluation of Susceptibility Testing Methods for Fosfomycin Against Enterobacteriaceae and Pseudomonas aeruginosa
por: De La Cadena, Elsa Piedad, et al.
Publicado: (2018) -
Molecular mechanisms leading to ceftolozane/tazobactam resistance in clinical isolates of Pseudomonas aeruginosa from five Latin American countries
por: Mojica, María F., et al.
Publicado: (2022) -
1592. In Vitro Activity of Ceftolozane/Tazobactam (C/T) Against Enterobacteriaceae and Pseudomonas aeruginosa Circulating in Chile
por: Rivas, Lina M, et al.
Publicado: (2019)